Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology is a prominent peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine. Published by KARE PUBL, this journal has established itself as a key resource for researchers, healthcare professionals, and students since its inception in 1990. As an Open Access journal since 2017, it ensures that cutting-edge research and clinical findings are readily accessible to a global audience, thus fostering collaboration and knowledge sharing among the cardiology community. With its recent rank in the Q3 quartile for Cardiology and Cardiovascular Medicine in 2023, and a Scopus rank of #282 out of 387, the journal is positioned to enhance its influence in the cardiovascular field, offering valuable insights and promoting evidence-based practices. The journal covers a wide range of topics within cardiology and cardiovascular research, making it an essential platform for scholars aiming to contribute to the ongoing dialogue in this vital area of medicine. For those eager to stay updated with the latest research trends and clinical practices in cardiology, Turk Kardiyoloji Dernegi Arsivi represents a crucial resource.

Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.

CURRENT PROBLEMS IN CARDIOLOGY is a leading peer-reviewed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of cardiology through comprehensive analyses of contemporary challenges faced by cardiovascular practitioners. With its ISSN 0146-2806 and E-ISSN 1535-6280, this esteemed journal has been a crucial resource for researchers, clinicians, and students alike since its inception in 1976, and continues to publish groundbreaking studies and reviews up until 2024. As a testament to its scholarly impact, CURRENT PROBLEMS IN CARDIOLOGY boasts a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in the broader category of Medicine (miscellaneous) in the 2023 metrics, positioning it among the top journals in its field. With a Scopus ranking of #127 out of 387 in Cardiology, and a 67th percentile ranking, it remains a vital platform for disseminating high-quality research that addresses critical issues in cardiovascular health. Researchers and practitioners looking to stay at the forefront of cardiac medicine will find this journal an indispensable tool for informed decision-making and practice improvement.

CLINICAL SCIENCE, published by PORTLAND PRESS LTD, is a prestigious journal with an established history that dates back to 1946. Renowned for its rigorous peer-reviewed articles, the journal is dedicated to advancing knowledge in the field of medicine, particularly in the nuances of clinical science and translational research. With an impressive Q1 ranking in the **Medicine (miscellaneous)** category and a Scopus rank of #32 out of 636 in general medicine, it is firmly positioned in the top 5% percentile of its field, making it an essential resource for researchers, practitioners, and students aiming to stay at the forefront of the discipline. Although the journal operates on a traditional subscription model, its influence and accessibility ensure that critical findings and innovative methodologies reach a wide audience, fostering collaboration and progress within the global medical community. The journal seeks to publish groundbreaking studies, critical reviews, and insights that can translate into improved clinical practices, thus reinforcing its mission to enhance patient care and medical knowledge.

The Monaldi Archives for Chest Disease, published by PAGEPRESS PUBL, is a vital resource for researchers and healthcare professionals dedicated to the fields of cardiology and pulmonary medicine. With an ISSN of 1122-0643 and an E-ISSN of 2532-5264, this Open Access journal has been committed to disseminating high-quality research since 2004, ensuring that findings in chest disease are easily accessible to a global audience. Based in Italy, the journal features contributions that reflect a broad scope of topics within its fields, achieving a Q3 ranking in both Cardiology and Cardiovascular Medicine, as well as in Pulmonary and Respiratory Medicine as of 2023. The journal's Scopus ranks place it at 168th out of 387 in its cardiology category and 83rd out of 155 in pulmonary medicine, indicating its relevance in the academic landscape. With its commitment to advancing knowledge and practice, the Monaldi Archives for Chest Disease stands as an essential platform for publication and dialogue in chest disease research, appealing to a diverse audience of scholars and practitioners.

Journal of Cardiovascular Emergencies is a premier open-access journal dedicated to advancing the field of emergency cardiovascular care. Published by SCIENDO, the journal has been an essential resource for healthcare professionals since its inception in 2015, prioritizing the dissemination of cutting-edge research, case studies, and reviews that address acute cardiovascular conditions. With the ISSN 2457-5518 and E-ISSN 2457-550X, it stands as a valuable platform for researchers and practitioners alike, offering insights that can lead to improved patient outcomes in emergency settings. The journal, based in Warsaw, Poland, aims to foster collaboration and knowledge exchange within the growing community of cardiology and emergency medicine professionals. By making its content freely accessible, the Journal of Cardiovascular Emergencies underscores the importance of knowledge sharing in tackling the challenges presented by cardiovascular emergencies on a global scale.

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.

Nature Cardiovascular Research, published by SpringerNature in Germany, stands as a premier journal dedicated to advancing the field of cardiovascular sciences. With an impressive 2023 categorization in the Q1 quartile across multiple disciplines—including Biochemistry, Genetics and Molecular Biology, Cardiology, and Medicine—this journal uniquely positions itself as a leading resource for pioneering research and innovative findings. Although currently not open access, it provides a rich repository of peer-reviewed articles that contribute directly to the evolving landscape of cardiovascular medicine. The journal aims to bridge the knowledge gap between basic science and clinical application, catering to researchers, healthcare professionals, and students alike who are immersed in the complexities of cardiovascular health. With robust Scopus rankings in key categories, Nature Cardiovascular Research is poised to shape future directions in the field, helping to foster a deeper understanding of cardiovascular diseases and their underlying mechanisms. Explore the latest research and be part of the conversation in one of the most impactful scientific domains.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is a leading peer-reviewed journal dedicated to the exploration and advancement of pharmacological therapies related to cardiovascular diseases. With its ISSN 0160-2446 and E-ISSN 1533-4023, this esteemed journal has been at the forefront of cardiovascular research since its inception in 1979, continuously offering insights until 2024. It holds a commendable position in the 2023 category quartiles, classified as Q2 in both Cardiology and Cardiovascular Medicine, as well as Medicine (miscellaneous) and Pharmacology, showcasing its significance within these fields. The journal presents a unique platform for researchers, health professionals, and students to disseminate their findings, fostering an environment of knowledge growth and collaboration in cardiovascular pharmacology. Readers can expect to find high-quality articles that contribute to the body of knowledge in cardiovascular therapies, ensuring they remain informed of the latest advancements and clinical practices. Discover more about this influential publication and its commitment to enhancing cardiovascular health.